Cite
APA Citation
Makras, P., & Anastasilakis, A. D. (2021). questions and facts regarding denosumab discontinuation among postmenopausal women. Expert opinion on drug safety, 20(5), 499–501. http://access.bl.uk/ark:/81055/vdc_100129572573.0x000026